It's been a year or so since I posted about my suspicions that I was approaching biochemical recurrence territory. Here's what's been happening in the meantime:
Onco had always said that if/when the PSA reached or progressed beyond the 0.20 mark I would be referred for a PSMA PET scan and true to her word I underwent an 18F PET PSMA scan at UCLH in June 2020 (when my PSA was somewhere between 0.22 and 0.27). The scan was completely clear which, of course, is very reassuring.
My Onco had been toying with the thought that the PSA might be coming from residual benign prostate cells left behind after my multi-modal primary treatments (RARP then salvage RT and HT [see my bio for full details]). Given the latest jump from 0.27 to 0.47 over 2 months I remain to be convinced. As you can see by the frequency of PSA testing, my Onco is keeping a very close eye on me which, whilst reassuring, is also somewhat anxiety-inducing.
Any thoughts on what this PSA pattern is likely to be pointing to in terms of localised recurrence versus micro mets etc? And what, if any, are the likely treatment options going forward? Though extremely effective, I had a very bad time whilst on HT (Bicalutamide/Zoladex) for 24 months as part of the RT/HT package so if, as I imagine, that's a likely treatment modality, I'd like to hold off for as long as possible. Where does Chemo fit into the equation (if indeed it does) in this scenario?
Thanks, in advance, for your input and advice.
Edited by member 20 Sep 2020 at 16:08
| Reason: Typos